0000899243-20-005933.txt : 20200226 0000899243-20-005933.hdr.sgml : 20200226 20200226174843 ACCESSION NUMBER: 0000899243-20-005933 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200224 FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goeltz II Robert C. CENTRAL INDEX KEY: 0001653881 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38470 FILM NUMBER: 20657523 MAIL ADDRESS: STREET 1: 343 OYSTER POINT BLVD STREET 2: SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unity Biotechnology, Inc. CENTRAL INDEX KEY: 0001463361 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264726035 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3280 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: (415) 328-5504 MAIL ADDRESS: STREET 1: 3280 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: Cenexys, Inc. DATE OF NAME CHANGE: 20130703 FORMER COMPANY: FORMER CONFORMED NAME: Forge Inc DATE OF NAME CHANGE: 20090504 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-24 0 0001463361 Unity Biotechnology, Inc. UBX 0001653881 Goeltz II Robert C. C/O UNITY BIOTECHNOLOGY, INC. 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Financial Officer Common Stock, $0.0001 par value 2020-02-24 4 M 0 10000 3.43 A 134404 D Stock Option (Right to Buy) 3.43 2020-02-24 4 M 0 10000 0.00 D 2027-09-26 Common Stock 10000 110620 D The transaction reported in this Form 4 relates to the exercise of an in-the-money stock option with cash by Reporting Person. The underlying shares vest pursuant to the following schedule: Twenty Five Percent (25%) of the shares subject to the option vested on September 5, 2018 (the "Vesting Commencement Date"), and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. /s/ Tamara L. Tompkins, Attorney-in-Fact for Robert C. Goeltz 2020-02-26